baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

ABBVIE INC./ US00287Y1091 /

8/5/2022 12:00:00 AM	Chg. -	Volume	Bid-	Ask-	Market Capitalization	Dividend Y.	P/E Ratio
2,825.00MXN	-	848 Turnover: -	-Bid Size: -	-Ask Size: -	5024.28 bill.MXN	-	-

GlobeNewswire 3/28 Triller, Who Recently Announced a Go-Public Transaction With Nasdaq Listed SEAC, to Acquire Fast-Gro...

GlobeNewswire 3/28 HCW Biologics Reports Fourth Quarter and Full Year 2021 Financial Results and Business Highlights fo...

GlobeNewswire 3/25 Morphic Therapeutic Announces Initiation of EMERALD-1 Phase 2a Clinical Trial of MORF-057 in Patient...

GlobeNewswire 3/24 Athira Pharma Reports Full Year 2021 Financial Results and Provides Clinical Update

GlobeNewswire 3/24 Sosei Heptares Confirms Senior Leadership Changes to Drive the Company Through the Next Stage of its...

GlobeNewswire 3/23 CytomX Therapeutics Announces Retirement of Frederick W. Gluck from Board of Directors

GlobeNewswire 3/21 Caribou Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corpora...

GlobeNewswire 3/18 Nitrase Therapeutics Announces Major Discovery In Parkinson’s Disease Presented At The AD/PD Interna...

GlobeNewswire 3/17 CytomX Therapeutics to Present Updated Preclinical Data for Conditionally Activated Cytokine Program...

GlobeNewswire 3/17 Synlogic Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update

GlobeNewswire 3/15 Molecular Partners Reports Corporate Highlights From Q4 2021 and Key Financials for Full Year 2021

GlobeNewswire 3/10 Assembly Biosciences Reports Fourth Quarter and Year End 2021 Financial Results and Recent Highlight...

GlobeNewswire 3/10 Harpoon Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corpor...

GlobeNewswire 3/8 Voyager Therapeutics Reports Fourth Quarter and Full Year 2021 Financial and Operating Results

GlobeNewswire 3/8 Inventiva announces that its IND application for the Phase II combination trial with lanifibranor a...

GlobeNewswire 3/7 Inventiva reports its 2021 Full-Year Results: key milestones achieved with lanifibranor in NASH and ...

GlobeNewswire 3/7 Inventiva publie ses résultats annuels 2021 : Avancées majeures avec lanifibranor dans la NASH et ce...

GlobeNewswire 3/4 Morphic Announces Participation In Cowen 42nd Annual Healthcare Conference

GlobeNewswire 3/3 Royalty Pharma to Present at Cowen's 42nd Annual Health Care Conference

GlobeNewswire 3/2 Harpoon Therapeutics Receives FDA Fast Track Designation for HPN217

GlobeNewswire 3/1 Miromatrix Names Jim Douglas as New Chief Financial Officer

GlobeNewswire 3/1 CytomX Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results, and Provides Busine...

GlobeNewswire 3/1 Inventiva announces participation at several conferences in March 2022

GlobeNewswire 2/28 Inventiva announces the schedule of publication and presentation of its 2021 Full-Year Financial Res...

GlobeNewswire 2/28 CytomX Therapeutics to Present at Cowen 42nd Annual Healthcare Conference

ABBVIE INC./ US00287Y1091 /

If you wish to receive reply to your feedback, please provide your email address.